According to MeiraGTx's latest financial reports the company's current revenue (TTM ) is โฌ29.87 Million. In 2024 the company made a revenue of โฌ31.98 Million an increase over the revenue in the year 2023 that were of โฌ12.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | โฌ32.39 M | 1.3% |
2024 | โฌ31.98 M | 152.21% |
2023 | โฌ12.67 M | -14.56% |
2022 | โฌ14.84 M | -55.42% |
2021 | โฌ33.29 M | 163.09% |
2020 | โฌ12.65 M | 6.64% |
2019 | โฌ11.86 M | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | โฌ0.53 B | 1,701.64% | Jersey |
![]() Novavax NVAX | โฌ1.05 B | 3,419.88% | ๐บ๐ธ USA |
![]() Organovo ONVO | โฌ0.12 M | -99.58% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | โฌ18.9 M | -36.71% | ๐ฌ๐ง UK |